J. B. CHEMICALS & PHARMACEUTICALS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,801 INR | +2.03% |
|
-4.64% | +10.88% |
Presenter SpeechAnuj Sonpal (Analysts)Thank you, Verizon. Good afternoon, everyone, and a warm...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
J. B. Chemicals & Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is engaged in the business of manufacturing and marketing of diverse range of pharmaceutical formulations, herbal remedies and active pharmaceutical ingredients (APIs). Its therapeutic categories include gastroenterology, hypertension, diabetes, dermatology, nephrology, wound care, anti-infectives and pharmacovigilance. The Company's lozenges products include center-filled, soft-centered lozenges; center-filled, powder lozenges; herbal lozenges, and medicated lozenges. The Company offers a complete range of contrast media products including X-ray, MRI, and ultrasound in India as well as internationally. The Company produces a wide range of dosage forms, such as tablets, capsules, liquids, IV infusions, ampoules, vials, ointments, cold rubs, lozenges and sips. Its brands include Rantac OD, RD, Ranraft, Metrogyl ER, Metrogyl O, Nicardia XL, Sporlac EVA and Sporlac G, among others.
Sector
Pharmaceuticals
Calendar
2024-05-22
- Q4 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
1,801
INR
Average target price
1,882
INR
Spread / Average Target
+4.47%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +10.88% | 3.35B | |
| +30.38% | 684B | |
| +26.51% | 568B | |
| -4.36% | 361B | |
| +19.30% | 329B | |
| +3.73% | 284B | |
| +16.70% | 240B | |
| +8.78% | 208B | |
| -7.93% | 200B | |
| +7.68% | 166B |
- Stock Market
- Equities
- JBCHEPHARM Stock
- News J. B. Chemicals & Pharmaceuticals Limited
- Transcript : J. B. Chemicals & Pharmaceuticals Limited, Q4 2020 Earnings Call, Jul 06, 2020
